Service Optimisation & Formulary

Advancing Equitable & Sustainable Healthcare

Bayer is committed to ensuring all patients have access to the clinically appropriate treatment and care they need. We have developed a number of resources to help you to identify your priorities and support you in your decision making so that we reduce variation, health inequalities and optimise treatment in the NHS.

Hero Image_Equitable and Sustainable Healathcare - 1080 x1080

Population Health Management - Concept vs Reality

Listen to an expert panel give an overview and bring to life the importance of population health management in improving health outcomes for individuals and communities, and how it can be leveraged to address healthcare disparities.

The Importance of Population Health Management
Population Health Management - Concept vs Reality
Health Population and Menopause Treatment
Population Health Management - Concept vs Reality
Population Health: A Practical Guide - Lipid Management
Population Health Management - Concept vs Reality

This webinar was initiated and fully funded by Bayer for PM Healthcare.  


What is Patient Level Information & Costing System (PLICS)?

Watch Patrick McGinley give a 15-minute introduction to PLICS including providing you with an insight into how it can be used and how it can help inform your decision making.

Duration - 15 minutes

What is Patient Level Information & Costing System (PLICS)?
Introduction to PLICS - Insights on how to use it | Kerendia®▼ (finerenone)

Addressing unmet need in chronic kidney disease and cardiovascular disease

Tackling CVD, including prevention, early detection and treatment remains a key national priority outlined in the NHS Long Term Plan.[1] CKD is recognised as a major risk factor for the development of CVD.[2] Currently there is significant unmet need across the detection and management of these conditions. Access the resources below to better understand why CVD and CKD should be prioritised and how Bayer can support the NHS to address the burden of these diseases.

Partnerships with Bayer - Targeting CKD
Addressing unmet need in chronic kidney disease. Kerendia®▼ (finerenone)
Partnerships with Bayer - Targeting CVD
Addressing unmet need in cardiovascular disease
Decisive Action needed to tackle chronic kidney disease
Reasons to care | Kerendia®▼ (finerenone)

Abbreviations

CKD - Chronic Kidney Disease

CVD - Cardiovascular Disease

 

PP-MACS-GB-0165 | August 2024


    • 1
      NHS - NHS Long Term Plan, available at: https://www.longtermplan.nhs.uk/ (accessed July 2024)
    • 2
      Jankowski J et al, Circulation, 2021; 143(11); 1157-1172.